BlijWerkt has been acquired by Mentha Capital
January 2020 — Gilde Healthcare Partners has sold BlijWerkt Groep B.V. to Mentha Capital.
BlijWerkt is a Dutch provider of occupational health services that help companies manage employee absenteeism. The firm reduces the costs of absenteeism by increasing the vitality of client organizations and their employees. It also manages the process of sick leave and reintegration. BlijWerkt combines the power of the bigger players with the flexibility and personal attention of the smaller ones. The company is headquartered in Woerden, the Netherlands and is owned by Gilde Healthcare Partners, a Dutch private equity investor, since 2011. BlijWerkt has a diversified client base and is mainly active in the healthcare, government and educational sectors. The Group’s solutions are a high impact, mandatory service of negligible cost to its clients, which results in recurring revenues of +95%.
Mentha Capital is an independent investment company that focuses on the lower-end of the mid-market in the Benelux. Mentha invests in established, medium-sized and profitable companies that have the opportunity to grow further through a buy-and-build strategy, expansion into new markets or an organizational transition. With more than €400 million under management, Mentha works actively with entrepreneurs to support their companies in realizing their ambitious growth plans.
Gilde Healthcare is a specialized European healthcare investor managing €1 billion across two fund strategies: venture and growth capital and private equity. Gilde Healthcare's venture and growth capital fund invests in health tech and therapeutics. The venture and growth companies are based in Europe and North America. Gilde Healthcare's private equity fund invests in profitable European lower mid-market healthcare companies with a focus on the Benelux and DACH region. The private equity fund targets healthcare providers, suppliers of medical products and service providers in the healthcare market.
Our role in the transaction
Oaklins’ team in the Netherlands acted as the exclusive M&A advisor to the shareholders of BlijWerkt Groep B.V., including the majority shareholder Gilde Healthcare Partners.
Hugo de Bruin
Partner, Gilde Healthcare Partners
Talk to the deal team
Frederik van der Schoot
Oaklins Netherlands
Related deals
Comtax has been acquired by Ryan
Comtax, a São Paulo-based tax technology consultancy specializing in tax determination and digital tax compliance, had been acquired by Ryan, the world’s largest firm dedicated exclusively to business taxes. The transaction marks Ryan’s entry into the Brazilian market, adding a specialized team and an established base of large corporate clients in Brazil, one of the world’s most complex tax environments, at a time when the country’s consumption tax reform is set to reshape how companies calculate and report indirect taxes. For Comtax, the acquisition brings access to Ryan’s global platform, technology and client network across more than 80 countries, creating opportunities to scale its tax determination and compliance offering beyond its current footprint. Comtax’s founders will continue to lead the business.
Learn moreCibus has acquired Aweta from Standard Investment
Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.
Learn moreKatalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Learn more